AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 284: E549-E556, 2003. First published December 10, 2002; doi:10.1152/ajpendo.00379.2002
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/3/E549    most recent
00379.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mittendorfer, B.
Right arrow Articles by Klein, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittendorfer, B.
Right arrow Articles by Klein, S.
Vol. 284, Issue 3, E549-E556, March 2003

Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity

Bettina Mittendorfer, Bruce W. Patterson, and Samuel Klein

Department of Internal Medicine and Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri 63110

The effects of obesity and weight loss on lipoprotein kinetics were evaluated in six lean women [body mass index (BMI): 21 ± 1 kg/m2] and seven women with abdominal obesity (BMI: 36 ± 1 kg/m2). Stable isotope tracer techniques, in conjunction with compartmental modeling, were used to determine VLDL-triglyceride (TG) and apolipoprotein B-100 (apoB-100) secretion rates in lean women and in obese women before and after 10% weight loss. VLDL-TG and VLDL-apoB-100 secretion rates were similar in lean and obese women. Weight loss decreased the rate of VLDL-TG secretion by ~40% (from 0.41 ± 0.05 to 0.23 ± 0.03 µmol · kg fat-free mass-1 · min-1; P < 0.05). The relative decline in VLDL-TG produced from nonsystemic fatty acids, derived from intraperitoneal and intrahepatic TG, was greater (61 ± 7%) than the decline in VLDL-TG produced from systemic fatty acids, predominantly derived from subcutaneous TG (25 ± 8%; P < 0.05). Weight loss did not affect VLDL-apoB-100 secretion rate. We conclude that weight loss decreases the rate of VLDL-TG secretion in women with abdominal obesity, primarily by decreasing the availability of nonsystemic fatty acids. There is a dissociation in the effect of weight loss on VLDL-TG and apoB-100 metabolic pathways that may affect VLDL particle size.

lipoprotein; fatty acids; lipolysis


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. C. Gormsen, B. Nellemann, L. P. Sorensen, M. D. Jensen, J. S. Christiansen, and S. Nielsen
Impact of body composition on very-low-density lipoprotein-triglycerides kinetics
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E165 - E173.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Magkos, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer
A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1568 - E1574.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. Magkos, B. W. Patterson, and B. Mittendorfer
Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics
J. Lipid Res., May 1, 2007; 48(5): 1204 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Magkos, B. W. Patterson, and B. Mittendorfer
No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1243 - E1249.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. C. Gormsen, M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen
Energy expenditure, insulin, and VLDL-triglyceride production in humans
J. Lipid Res., October 1, 2006; 47(10): 2325 - 2332.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. G. Parhofer and P. H. R. Barrett
Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies
J. Lipid Res., August 1, 2006; 47(8): 1620 - 1630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Magkos, D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer
Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E355 - E362.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
W. L. Isley, J. M. Miles, B. W. Patterson, and W. S. Harris
The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus
J. Lipid Res., January 1, 2006; 47(1): 193 - 200.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online